retatrutide on the market Retatrutide, a new weight loss drug not available yet, is showing promising results in trials. Dr. LaPook explains it’s doing much more than what current medications can. | CBS News Retatrutide is an experimental weight-loss

Therefore, exploring the potential of L-carnitine in improving complications among preterm infants and their corresponding short- and long-term outcomes may provide new interesting research opportunities toward further optimizing the treatment of preterm infants

Doctors are concerned with the potential harmful effects on an infants growth and feeding if GLP-1s get into the bloodstream

ePocrates online

Weight regain after stopping Zepbound is not a treatment failure but rather reflects the chronic nature of obesity as a disease

Prompt therapy with widely available over-the-counter therapies is an initial step in treating these side effects and potentially increasing adherence to the GLP-1 regimen prescribed for Type 2 diabetes and obesity

A new method of delivering antibiotics via utilizing magnetic nanoparticles (MNPs) linked with a cell-penetrating peptide (CPP) was designed by Zhang and colleagues